Home >> Marketplace Archives >> Recombinant beta-2 microglobulin

Recombinant beta-2 microglobulin

Print Friendly, PDF & Email

October 2018—Bio-Rad announced the launch of recombinant beta-2 microglobulin from the company’s line of critical raw materials. This recombinant sourced tumor marker protein offers consistency and security over materials harvested from human sources. β2M is an 11 kD prognostic tumor marker and light chain of the class one major histocompatibility complex located on the surface of many cells. It is also found in the serum in a free form. Levels of β2M elevated in the blood are correlated with a larger amount of tumor and reduced kidney function in multiple myeloma patients.

Bio-Rad, 207-615-0571


Check Also

Quality controls, critical raw materials, 10/16

October 2016—Bio-Rad Laboratories launched Amplichek II quality control, which was issued a de novo clearance from the FDA. Amplichek II is the first in a series of infectious disease controls that the company is introducing to the molecular diagnostic testing market. It is an independent, multianalyte quality control that monitors the performance of in vitro laboratory nucleic acid testing procedures for the qualitative detection of health care–associated infections.